AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies

 AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies

AbCellera Enters into a Collaboration and License Agreement with Salipro to Boost Therapeutic Antibodies

Shots:

  • Salipro to receive an up front, research payments and is eligible for a downstream milestones for several targets
  • The collaboration will allow AbCellera to access Salipro Biotech’s expertise and its platform to produce stable Ag of membrane protein drug targets in drug discovery programs for therapeutic Abs
  • Salipro Biotech has signed multiple research collaborations with pharma and biotech companies. Salipro will be responsible to accelerates the novel drugs discovery

Click here to­ read full press release/ article | Ref: PR Newswire | Image: PR Newswire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post